ArticleScientific reports2026
Assessment of a modified Coronavirus Disease Optimization Algorithm for Parameter Estimation of Proton Exchange Membrane Fuel Cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parameter identification of a proton exchange membrane fuel cell (PEMFC) involves estimating the unknown model parameters required to build an accurate predictive representation of fuel-cell performance using optimization-based techniques. Because these parameters are often unavailable in manufacturer datasheets, their estimation is crucial for reliable performance prediction and system evaluation. In this work, a memory-based Coronavirus Disease Optimization Algorithm (mCOVIDOA) is proposed as an enhanced optimization method for extracting PEMFC parameters. Six unknown model parameters are identified and compared using six optimization approaches: mCOVIDOA, the standard Coronavirus Disease Optimization Algorithm (COVIDOA), Tunicate Swarm Algorithm (TSA), Grey Wolf Optimizer (GWO), Chimp Optimization Algorithm (ChOA), and Moth-Flame Optimizer (MFO). During the optimization process, these parameters are treated as decision variables, and the objective is to minimize the sum of squared errors (SSE) between simulated and measured cell voltages. The results show that mCOVIDOA achieves a lower SSE (1.9454) and consistently outperforms the original COVIDOA as well as GWO, TSA, ChOA, and MFO in terms of convergence quality and solution accuracy. Owing to its accurate prediction capability and faster convergence, mCOVIDOA shows strong potential for digital-twin development of fuel-cell systems and advanced control applications in automotive energy systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.